Anti-EGFR drug conjugates for the treatment of colorectal and breast cancer

Lead researcher

A/Prof Hui Gan, Prof Andrew Scott, Prof John Mariadason, A/Prof Elgene Lim, Prof Niall Tebbutt

Institution

La Trobe University

Years funded

2017-2019

This project explores exciting new drugs for colorectal and breast cancer patients which are highly targeted and very potent. The results could lead to better treatments for these patients.

Funding Body

Cancer Council Research Grant

Funding

$97,000 in 2017, $100,000 in 2018 and $95,000 in 2019

Updated: